Journal article
Dabigatran and risk of myocardial infarction
Abstract
Dabigatran has been associated with an increase in acute coronary events when compared with warfarin in several randomized trials, and now in a meta-analysis by Uchino and Hernandez. We critically review the evidence for this association and consider the implications for patient care.
Authors
Eikelboom JW; Weitz JI
Journal
Nature Reviews Cardiology, Vol. 9, No. 5, pp. 260–262
Publisher
Springer Nature
Publication Date
May 2012
DOI
10.1038/nrcardio.2012.34
ISSN
1759-5002